JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia.

M. F. Johan, D. T. Bowen, M. E. Frew, A. C. Goodeve, J. T. Reilly, Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia British Journal of Haematology. ,vol. 129, pp. 60- 65 ,(2005) , 10.1111/J.1365-2141.2005.05412.X

Robert Kralovics, Francesco Passamonti, Andreas S. Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R. Passweg, Andre Tichelli, Mario Cazzola, Radek C. Skoda, A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders The New England Journal of Medicine. ,vol. 352, pp. 1779- 1790 ,(2005) , 10.1056/NEJMOA051113

David P. Steensma, Gordon W. Dewald, Terra L. Lasho, Heather L. Powell, Rebecca F. McClure, Ross L. Levine, D. Gary Gilliland, Ayalew Tefferi, The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes. Blood. ,vol. 106, pp. 1207- 1209 ,(2005) , 10.1182/BLOOD-2005-03-1183

Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli, Jean Luc Villeval, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature. ,vol. 434, pp. 1144- 1148 ,(2005) , 10.1038/NATURE03546

Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Wlodarska, Jennifer J. Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. ,vol. 7, pp. 387- 397 ,(2005) , 10.1016/J.CCR.2005.03.023

Nancy Lee Harris, Elaine S. Jaffe, Jacques Diebold, Georges Flandrin, H. Konrad Muller-Hermelink, James Vardiman, T. Andrew Lister, Clara D. Bloomfield, World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology. ,vol. 17, pp. 3835- 3849 ,(1999) , 10.1200/JCO.1999.17.12.3835

E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin, Mike A Scott, Wendy N Erber, Anthony R Green, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders The Lancet. ,vol. 365, pp. 1054- 1061 ,(2005) , 10.1016/S0140-6736(05)71142-9